The German CDMO will operate as commercial manufacturer in Europe for Zynteglo, bluebird bio's first gene therapy to gain regulatory approval
Get your tickets before 10 February and save £50 before our early bird rate ends.
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.